Home › Vascular Diseases › Michigan › Detroit
Vascular Diseases clinical trials in Detroit, MI
4 studies for Vascular Diseases are looking for participants at sites in and around Detroit (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Recruiting
- Henry Ford Hospital, Detroit
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RecruitingPhase 2
- Clinical Research Site, Detroit
Global Paradise System US Post Approval Study
RecruitingObservational study
- Henry Ford Health, Detroit
- Henry Ford St. John Hospital, Detroit
The RADIANCE CED Study
RecruitingObservational study
- Henry Ford Hospital, Detroit
- Henry Ford St. John Hospital, Detroit
About Vascular Diseases
Your vascular system is made up of blood vessels that carry blood to and from the heart. Learn about vascular diseases and their treatments.
More about Vascular Diseases on MedlinePlus
Vascular Diseases trials in other cities
- Boston, MA13 studies
- Washington, DC7 studies
- New York City, NY5 studies
- Mountain View, CA4 studies
- Tampa, FL4 studies
- Atlanta, GA4 studies
- Los Angeles, CA4 studies
- St. Louis, MO4 studies
- Cleveland, OH4 studies
- Dallas, TX4 studies
- Durham, NC4 studies
- Chicago, IL3 studies
Other studies in Detroit
- Non-Small Cell Lung Cancer44 studies
- Breast Cancer33 studies
- Cancer (all types)29 studies
- Colorectal Cancer26 studies
- Ovarian Cancer26 studies
- Metastatic Cancer24 studies
- Prostate Cancer22 studies
- Endometrial Cancer21 studies
- Lung Cancer20 studies
- Multiple Myeloma19 studies
- Stomach Cancer16 studies
- Head and Neck Squamous Cell Carcinoma15 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.